Independent. Trusted. Proven.
Investment analysis, share recommendations, and market insights.
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk at Morgans, notes that Morgans research team maintains a BUY rating on Sonic Healthcare (SHL).
Here are the reasons I think higher inflation is here to stay – and how investors can respond by focusing on assets suited to those conditions.
In our “HOT” stock article, Michael Gable, Managing Director of Fairmont Equities, explains why he sees South32 (S32) offering an opportunity at its current levels.
This is a crucial question for all investors because if I predict a sell-off and I’m right, then being defensive, say in cash, will get you around 4% while those exposed to growth could lose 15% or more.
Let’s take a look at how our model portfolios have performed so far in 2025. We’ll start by examining how the overall market has fared.
Here are three stocks that I’d like to see under our Christmas tree with my name on the gift card!
In our HOT stock column today, Raymond Chan, Adviser & Head of Asian Desk at Morgans, noted that our research team has added Aristocrat Leisure (ALL) to the “Best Ideas” list following price weakness.
My sense is investors will benefit from having more portfolio cash in 2026 and a higher weighting in fixed income. In the past few months, I’ve highlighted cash Exchange Traded Funds (ETFs). This week, my focus turns to fixed-income ETFs and here are two of them.
Michael Gable, Managing Director of Fairmont Equities, explains why RIO appears almost ready to break above $135 and would be a BUY if that occurs.
The ETF EX20 has been a good performer over the past two years, helped by falling interest rates. But with rate cuts on hold (or done and dusted), should we reduce our exposure to EX20?
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.